APRE Aprea Therapeutics, Inc.

NASDAQ

$0.76

Aprea Therapeutics, Inc. (APRE) Earnings News

Earnings press releases, previews and reviews for Aprea Therapeutics, Inc. (APRE), newest first.

Wednesday August 12, 2026 8:30 AM ET

Aprea Therapeutics Announces Second Quarter 2026 Financial Results

Wednesday May 13, 2026 6:30 AM ET

Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update